Custom G4 Microarrays for Ligand Binding Selectivity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current techniques face challenges in conducting high-throughput examinations of the sequence specificity of non-B-DNA binding proteins, particularly for G-quadruplexes, due to limitations in analyzing the binding of proteins and small molecules to G-quadruplex structures, which are crucial for understanding gene regulation and therapeutic targeting.

Innovation Solution

The development of custom DNA microarrays containing thousands of unique G-quadruplex-forming sequences allows for the assessment of binding specificity of proteins and small molecules, using fluorescently labeled compounds like Cy5-PDS and Cy5-BG4, and competition experiments with BMVC to determine selective binding profiles across diverse G-quadruplex structures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If custom G4 microarrays with thousands of unique sequences are used, then high-throughput assessment of ligand binding selectivity is improved, but device complexity and manufacturing difficulty increase

Engineering Contradiction:
Improvehigh-throughput assessment capabilityVSAvoidmicroarray design complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The microarray is divided into multiple distinct design regions (Design 1 with 2,264 sequences, Design 2 with 18,512 sequences, Design 3 with 15,671 sequences), each targeting specific G4 structural features. This segmentation allows systematic evaluation of different sequence parameters while maintaining manageable complexity for each design module.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the microarray are optimized for specific purposes: some regions focus on loop length variations, others on tail sequence diversity, and others on core G4 structure variations. This local optimization enables targeted assessment of specific binding preferences without requiring all sequences to be equally complex.

Inventive Principle:
Principle #3Local quality

2Measurement precision

If comprehensive G4 sequence coverage is achieved, then binding specificity assessment accuracy is improved, but manufacturing precision and array design difficulty increase

Engineering Contradiction:
Improvebinding specificity assessment accuracyVSAvoidmicroarray fabrication accuracy
Core Design Contradiction:
Measurement precisionVSManufacturing precision

Solution Approach 1:

The microarray systematically varies specific parameters (loop length from 2-10 nucleotides, tail sequence composition, core G4 structure) while controlling other factors. This parameter-based design enables comprehensive coverage of G4 sequence space with manageable manufacturing complexity, as each parameter can be independently optimized and fabricated.

Inventive Principle:
Principle #35Parameter changes

3Difficulty of detecting and measuring

If fluorescent labeling of ligands is used, then detection sensitivity is improved, but potential interference with binding interactions may occur

Engineering Contradiction:
Improvebinding detection sensitivityVSAvoidfluorophore interference with binding
Core Design Contradiction:
Difficulty of detecting and measuringVSObject-affected harmful factors

Solution Approach 1:

The Cy5 fluorophore is attached to ligands such as pyridostatin and BMVC through linker chemistry that positions the fluorophore away from the binding interface. This intermediary approach enables sensitive detection of binding events while minimizing steric or electronic interference with the ligand-G4 interactions being studied.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables a robust and sensitive high-throughput analysis of G-quadruplex binding events, providing insights into sequence and structure-dependent interactions, and reveals distinct binding preferences of molecules, thereby facilitating the development of targeted therapeutic agents.

Implementation Method 1

using fluorescently labeled compounds like Cy5-PDS and Cy5-BG4, and competition experiments with BMVC to determine selective binding profiles

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20240393343A1Methods and materials for large-scale assessment of ligand binding selectivity of g-quadruplex recognition using custom g4 microarrays
Publication Date: 2024.11.28 PURDUE RES FOUND
  • US20240393343A1 patent drawing
  • US20240393343A1 patent drawing
  • US20240393343A1 patent drawing

AI summary

Described herein are devices and processes using single-stranded DNA sequences capable of forming G-quadruplexes (G4s) to assess the binding affinity and binding selectivity of potential G4-interactive ligands.